Evaluation research in health care regulation
Abstract
Regulatory intervention in health care markets must necessarily be based on a deep understanding of the organization and functioning of the health system, the incentives for providers and health professionals, the preferences and satisfaction of service users and the strategic choices of policy makers. In this context, a key activity for any regulator is the promotion of research to produce knowledge on all these issues. The Health Regulation Authority, as the regulator of health care in Portugal, conducts research activities as an essential starting point to properly directing the behavioural oversight activities, to design adequate regulatory interventions aimed at shaping the behaviour of agents, to promote the reduction of information asymmetries and to support policy making.
Downloads
References
in: Textos de Regulação da Saúde: Ano 2012, Entidade Reguladora da Saúde,
Porto, Portugal.
2. Donabedian, A (1966), “Evaluating the quality of medical care”, The Milbank
Memorial Fund Quarterly, Vol. 44, No. 3, pp. 166–203.
3. Hirschman, AO (1964), “The Paternity of an Index”, The American Economic
Review, Vol. 54, No. 5, pp. 761–762.
4. Mears et al. (2011), “Classifying indicators of quality: a collaboration between
Dutch and English regulators”, International Journal for Quality in Health Care,
Vol. 23, No. 6, pp. 637–644.
5. Penchansky, R, Thomas, JW (1981), “The Concept of Access: Definition and
Relationship to Consumer Satisfaction”, Medical Care, Vol. 19, No. 2, pp. 127–
140.
6. Powell, RR (2006), “Evaluation research: An overview”, Library Trends, Vol.
55, No. 1, (“Research Methods,” edited by Lynda M. Baker), pp. 102–120.
7. Weiss, CH (1998), “Evaluation: Methods for studying programs and policies
(2nd ed.)”, Prentice Hall, Upper Saddle River, NJ, USA.
